Yondelis (Ovarian Cancer) Analysis and Forecasts to 2020
Publisher Name » GlobalData
Published Date » 2011-10-20
No. Of Pages » 31
GlobalDatas pharmaceuticals report, Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Yondelis sales forecasts for EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.
Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.
Scope
- Therapy area profile including patient population for EU5
- Analysis and review of Yondelis including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of Yondelis including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecasts for 2009-2020 for Yondelis in EU
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drugs performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Contents
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Ovarian Cancer 4
2.2 Ovarian Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Age 6
2.4.2 Inherited Gene Mutations 6
2.4.3 A Previous Cancer Diagnosis 6
2.4.4 Early Menstruation or Late menopause 7
2.4.5 Family History of Ovarian Cancer 7
2.5 GlobalData Report Guidance 7
3 Ovarian Cancer: Market Characterization 8
3.1 Ovarian Cancer Market 8
3.2 Ovarian Cancer Market Forecasts and CAGR 8
3.3 Drivers for Ovarian Cancer Market 9
3.3.1 High Incidence 9
3.3.2 High Mortality Rate 10
3.3.3 Increased Use of Chemotherapy in Ovarian Cancer 11
3.3.4 Emergence of Targeted Drugs 11
3.3.5 Recurrence of Tumor 11
3.3.6 Low Initial Diagnosis Rate 11
4 Tumor-Node-Metastases (TNM) Classification of Ovarian Cancer 12
5 Yondelis (trabectedin) 15
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.4 Approval History of Yondelis 16
5.5 Factors Affecting Sales of Yondelis 16
5.5.1 Yondelis/Doxil Combination 16
5.5.2 Efficacy 16
5.5.3 Adverse Events 16
5.5.4 Orphan Drug Status 17
5.5.5 Licensing in Japan 17
5.5.6 Rejection by NICE in the UK 17
5.6 Drug Evaluation 17
5.6.1 Drug Risk Benefit Score 17
5.6.2 Intensity of Competition 18
5.7 Sales Estimates 18
5.7.1 Target Patient Pool of Yondelis 18
5.7.2 Dosing 19
5.7.3 Market Penetration 19
5.7.4 Annual Cost of Therapy 20
5.7.5 Sales Projections of Yondelis 20
6 Ovarian Cancer Market: Appendix 27
6.1 Market Definitions 27
6.2 List of Abberiviations 27
6.3 Research Methodology 27
6.3.1 Coverage 27
6.3.2 Secondary Research 28
6.3.3 Forecasting 28
6.3.4 Number of Patients Approved to take the Drug 28
6.3.5 Net Penetration of Drug 28
6.3.6 Net Annual Dosing 30
6.3.7 Annual Cost of Therapy 30
6.3.8 Primary Research 30
6.3.9 Expert Panels 30
6.4 Contact Us 30
6.5 Disclaimer 30
6.6 Sources 31
List of Tables
Table 1: Ovarian Cancer, Incidences and Mortality, 20082030 6
Table 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 8
Table 3: Detailed TNM Classification 13
Table 4: Phase III Clinical Study Results for Yondelis in Ovarian Cancer 16
Table 5: Approval History of Yondelis 16
Table 6: Drug Risk Benefit Score of Yondelis 17
Table 7: Annual Cost of Therapy of Yondelis, 2011 20
Table 8: Yondelis, Ovarian Cancer, EU-5, Sales Estimates ($m), 20092020 21
Table 9: Yondelis, Ovarian Cancer, The UK, Sales Estimates ($m), 20092020 21
Table 10: Yondelis, Ovarian Cancer, France, Sales Estimates ($m), 20092020 22
Table 11: Yondelis, Ovarian Cancer, Germany, Sales Estimates ($m), 20092020 23
Table 12: Yondelis, Ovarian Cancer, Italy, Sales Estimates ($m), 20092020 24
Table 13: Yondelis, Ovarian Cancer, Spain, Sales Estimates ($m), 20092020 25
List of Figures
Figure 1: Distribution by Incidence and Mortality, Most Commonly Diagnosed Cancers, Worldwide, 2010 5
Figure 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 8
Figure 3: Ovarian Cancer, Worldwide, Incidence (in million), 2008-2030 9
Figure 4: Oncology, Worldwide, Incidence (in million), 2008-2030 10
Figure 5: Ovarian Cancer, Worldwide, Mortality (in million), 2008-2030 10
Figure 6: Broad Classification of Ovarian Cancer 12
Figure 7: Classification of Ovarian Cancer 14
Figure 8: Drug Model Diagram of Yondelis 19
Figure 9: Yondelis, Ovarian Cancer, EU-5, Sales Estimates ($m), 20092020 20
Figure 11: Yondelis, Ovarian Cancer, The UK, Sales Estimates ($m), 20092020 21
Figure 12: Yondelis, Ovarian Cancer, France, Sales Estimates ($m), 20092020 22
Figure 13: Yondelis, Ovarian Cancer, Germany, Sales Estimates ($m), 20092020 23
Figure 14: Yondelis, Ovarian Cancer, Italy, Sales Estimates ($m), 20092020 24
Figure 15: Yondelis, Ovarian Cancer, Spain, Sales Estimates ($m), 20092020 25
Figure 16: Yondelis, Ovarian Cancer, Europe, Sales Distribution, 2019 26
Figure 17: Drug Model Diagram 29
Figure 18: Patients Approved for the Drug 29
Upcoming Reports:
|
Biofertilizers Market - Global Industry Analysis, Size, Share, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The demand for biofertilizers is witnessing strong growth since the last decade owing to its eco-friendly characteristics and a trend to reduce the reliance on chemically derived fertilizers. Biofertilizers are manufactured using living cells of microorganisms which help in the growth of crops by providing the required nutrients from the soil.
The global market for biofertilizers is expected to exceed a market worth USD 10.2 billion by 2018, growing at an approximate CAGR of 12.9% from 2012 to 2018. European and Latin American countries are the leading consumers...
|
|
Capacitive Sensors Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Description
Capacitive sensors are devices that enable the measurement of the position of a conductive or nonconductive surface. The high-resolution sensing ability of these sensors makes them highly popular in detection and measurement of position, proximity, acceleration, and fluid levels. Currently, capacitive sensing is widely being used in devices like mobile phones, tables, other mobile devices, laptop trackpads, and in many other applications.
The market for these sensors was valued at USD 7 billion in 2012 and is expected to grow at a CAGR of 13-14% from...
|
|
Thin Film Photovoltaics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Thin film photovoltaics are solar cells manufactured by placing one or more thin layers of photovoltaic material on a substrate. The thickness of such a layer varies widely ranging from few nanometers to a few micrometers. There are two leading manufactured solar photovoltaic (PV) technologies in commercial use today; crystalline silicon PV and thin-film PV.
There are various ways to manufacture a photovoltaic cell depending on which it is classified as follows :
Amorphous silicon and other thin film silicon
Cadmium telluride
Copper indium...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 Asian countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
